##fileformat=VCFv4.2
##PIPELINE=megSAP 0.1-1143-gd053876
##SAMPLE=<ID=FO00000x02_01,Gender=n/a,ExternalSampleName=272 T 17751/15,IsTumor=yes,IsFFPE=yes,DiseaseGroup=n/a,DiseaseStatus=n/a>
##SAMPLE=<ID=FO00000x01_01,Gender=n/a,ExternalSampleName=272 N 17751/15,IsTumor=no,IsFFPE=yes,DiseaseGroup=n/a,DiseaseStatus=n/a>
##INFO=<ID=variant_type,Number=.,Type=String,Description="Variant type.">
##INFO=<ID=coding_and_splicing,Number=.,Type=String,Description="Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).">
##INFO=<ID=regulatory,Number=.,Type=String,Description="Regulatory consequence details.">
##INFO=<ID=OMIM,Number=.,Type=String,Description="OMIM database annotation.">
##INFO=<ID=ClinVar,Number=.,Type=String,Description="ClinVar database annotation.">
##INFO=<ID=HGMD,Number=.,Type=String,Description="HGMD database annotation.">
##INFO=<ID=RepeatMasker,Number=.,Type=String,Description="RepeatMasker annotation.">
##INFO=<ID=dbSNP,Number=.,Type=String,Description="Identifier in dbSNP database.">
##INFO=<ID=1000g,Number=.,Type=String,Description="Allele frequency in 1000 genomes project.">
##INFO=<ID=gnomAD,Number=.,Type=String,Description="Allele frequency in gnomAD project.">
##INFO=<ID=gnomAD_hom_hemi,Number=.,Type=String,Description="Homoyzgous counts and hemizygous counts of gnomAD project (genome data).">
##INFO=<ID=gnomAD_sub,Number=.,Type=String,Description="Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.">
##INFO=<ID=ESP_sub,Number=.,Type=String,Description="Sub-population allele frequency (EA,AA) in NHLBI Exome Sequencing project.">
##INFO=<ID=phyloP,Number=.,Type=String,Description="phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.">
##INFO=<ID=Sift,Number=.,Type=String,Description="Sift effect prediction and score for each transcript: D=damaging, T=tolerated.">
##INFO=<ID=PolyPhen,Number=.,Type=String,Description="PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.">
##INFO=<ID=fathmm-MKL,Number=.,Type=String,Description="fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.">
##INFO=<ID=CADD,Number=.,Type=String,Description="CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.">
##INFO=<ID=REVEL,Number=.,Type=String,Description="REVEL pathogenicity prediction score. Deleterious threshold > 0.5.">
##INFO=<ID=MaxEntScan,Number=.,Type=String,Description="MaxEntScan splicing prediction (reference bases score/alternate bases score).">
##INFO=<ID=GeneSplicer,Number=.,Type=String,Description="GeneSplicer splicing prediction (state/type/coordinates/confidence/score).">
##INFO=<ID=dbscSNV,Number=.,Type=String,Description="dbscSNV splicing prediction (ADA/RF score).">
##INFO=<ID=COSMIC,Number=.,Type=String,Description="COSMIC somatic variant database anntotation.">
##INFO=<ID=tumor_af,Number=.,Type=String,Description="Mutant allele frequency in tumor (Sample FO00000x02_01).">
##INFO=<ID=tumor_dp,Number=.,Type=String,Description="Tumor Depth (Sample FO00000x02_01).">
##INFO=<ID=normal_af,Number=.,Type=String,Description="Mutant allele frequency in normal (Sample FO00000x01_01).">
##INFO=<ID=normal_dp,Number=.,Type=String,Description="Normal depth (Sample FO00000x01_01).">
##INFO=<ID=NGSD_som_c,Number=.,Type=String,Description="Somatic variant count in the NGSD.">
##INFO=<ID=NGSD_som_p,Number=.,Type=String,Description="Project names of project containing this somatic variant in the NGSD.">
##INFO=<ID=NGSD_hom,Number=.,Type=String,Description="Homozygous variant count in NGSD.">
##INFO=<ID=NGSD_het,Number=.,Type=String,Description="Heterozygous variant count in NGSD.">
##INFO=<ID=NGSD_group,Number=.,Type=String,Description="Homozygous / heterozygous variant count in NGSD with the same disease group (empty because group is n/a).">
##INFO=<ID=classification,Number=.,Type=String,Description="Classification from the NGSD.">
##INFO=<ID=classification_comment,Number=.,Type=String,Description="Classification comment from the NGSD.">
##INFO=<ID=validation,Number=.,Type=String,Description="Validation information from the NGSD. Validation results of other samples are listed in brackets!">
##INFO=<ID=comment,Number=.,Type=String,Description="Variant comments from the NGSD.">
##INFO=<ID=gene_info,Number=.,Type=String,Description="Gene information from NGSD (inheritance mode, gnomAD o/e scores).">
##FILTER=<ID=LowDepth,Description="Tumor or normal sample read depth at this locus is below 2">
##FILTER=<ID=LowEVS,Description="Somatic Empirical Variant Score (SomaticEVS) is below threshold">
##FILTER=<ID=all-unknown,Description="Allele unknown">
##FILTER=<ID=depth-nor,Description="Sequencing depth in normal is too low (< 20)">
##FILTER=<ID=depth-tum,Description="Sequencing depth in tumor is too low (< 20)">
##FILTER=<ID=freq-nor,Description="Allele frequency in normal > 0.17 * allele frequency in tumor">
##FILTER=<ID=freq-tum,Description="Allele frequency in tumor < 0.05">
##FILTER=<ID=lt-3-reads,Description="Less than 3 supporting tumor reads">
##FILTER=<ID=off-target,Description="Variant marked as 'off-target'.">
##FILTER=<ID=special-chromosome,Description="Special chromosome">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT
chr1	93303156	0.1674	C	T	494		normal_dp=165;quality=QUAL=156;gene=RPL5;variant_type=missense;coding_and_splicing=RPL5:ENST00000370321:missense_variant:MODERATE:exon6/8:c.671C>T:p.Ser224Phe:PF14204;regulatory=regulatory_region_variant:promoter;OMIM=603634 [RPL5 Diamond-Blackfan anemia 6,612561,Autosomal dominant];;phyloP=7.5720;Sift=D(0.03);PolyPhen=B(0.43);fathmm-MKL=0.96,0.97;CADD=23.70;REVEL=0.49;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=RPL5 (inh=AD oe_syn=1.04 oe_mis=0.59 oe_lof=0.00)	.
chr1	152058833	0.1556	G	A	2310		normal_dp=160;quality=QUAL=164;gene=TCHHL1;variant_type=missense;coding_and_splicing=TCHHL1:ENST00000368806:missense_variant:MODERATE:exon3/3:c.1325C>T:p.Ser442Phe:;phyloP=3.2150;Sift=D(0.00);PolyPhen=D(0.95);fathmm-MKL=0.46,0.53;CADD=22.90;REVEL=0.13;COSMIC=COSM1688546,COSM895968;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=TCHHL1 (inh=n/a oe_syn=1.18 oe_mis=1.05 oe_lof=0.00)	.
chr1	158585034	0.1740	G	T	1444		normal_dp=100;quality=QUAL=126;gene=SPTA1;variant_type=missense;coding_and_splicing=SPTA1:ENST00000368147:missense_variant:MODERATE:exon48/52:c.6760C>A:p.His2254Asn:PF00435;regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=182860 [SPTA1 Elliptocytosis-2,130600,Autosomal dominant/Pyropoikilocytosis,266140,Autosomal recessive/Spherocytosis,type 3,270970,Autosomal recessive];;phyloP=8.9920;Sift=D(0.00);PolyPhen=D(1.00);fathmm-MKL=0.99,0.99;CADD=28.70;REVEL=0.34;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=SPTA1 (inh=AR+AD oe_syn=1.16 oe_mis=1.16 oe_lof=0.39)	.
chr1	186643823	0.1302	G	T	2213		normal_dp=186;quality=QUAL=144;gene=PTGS2;variant_type=missense;coding_and_splicing=PTGS2:ENST00000367468:missense_variant:MODERATE:exon10/10:c.1477C>A:p.Leu493Ile:PF03098;phyloP=3.8700;Sift=T(0.10);PolyPhen=P(0.70);fathmm-MKL=0.91,0.95;CADD=23.30;REVEL=0.28;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=PTGS2 (inh=n/a oe_syn=1.12 oe_mis=0.61 oe_lof=0.10)	.
chr1	206646615	0.1721	G	A	964		normal_dp=66;quality=QUAL=100;gene=IKBKE;variant_type=synonymous,intron;coding_and_splicing=IKBKE:ENST00000367120:synonymous_variant:LOW:exon3/22:c.45G>A:p.Leu15=:PF00069,IKBKE:ENST00000537984:intron_variant:MODIFIER:exon2/20:c.-168-1059G>A::;phyloP=1.8850;fathmm-MKL=0.81,0.92;CADD=11.37;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=IKBKE (inh=n/a oe_syn=0.91 oe_mis=0.72 oe_lof=0.27)	.
chr1	219991344	0.1431	G	A	624		normal_dp=294;quality=QUAL=195;variant_type=intergenic;coding_and_splicing=::intergenic_variant:MODIFIER::::;dbSNP=rs200604309;phyloP=-0.5770;fathmm-MKL=0.01,0.12;CADD=9.49;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info= (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr2	48033789	0.1455	C	T	276		normal_dp=127;quality=QUAL=124;gene=MSH6,FBXO11;variant_type=missense&splice_region,intron;coding_and_splicing=MSH6:ENST00000234420:missense_variant&splice_region_variant:MODERATE:exon9/10:c.4000C>T:p.Arg1334Trp:,FBXO11:ENST00000405808:intron_variant:MODIFIER:exon3/3:c.169+1545G>A::,MSH6:ENST00000538136:missense_variant&splice_region_variant:MODERATE:exon9/10:c.3094C>T:p.Arg1032Trp:,MSH6:ENST00000540021:missense_variant&splice_region_variant:MODERATE:exon7/8:c.3610C>T:p.Arg1204Trp:;OMIM=600678 [MSH6 Colorectal cancer,hereditary nonpolyposis,type 5,614350,Autosomal dominant/Endometrial cancer,familial,608089/Mismatch repair cancer syndrome,276300,Autosomal recessive],607871 [FBXO11 Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,618089,Autosomal dominant];;ClinVar=184389 [uncertain significance DISEASE=Hereditary nonpolyposis colon cancer,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified,not provided];;dbSNP=rs773763465;gnomAD=0.0001;gnomAD_hom_hemi=0,.;gnomAD_sub=0.0001,0.0001,0.0000,0.0001,0.0001;phyloP=2.8010;Sift=D(0.00), ,D(0.00),D(0.00);PolyPhen=D(0.95), ,D(0.95),D(0.94);fathmm-MKL=0.87,0.95;CADD=33.00;REVEL=0.66;MaxEntScan=6.25>4.27;dbscSNV=0.129/0.324;COSMIC=COSM1291512;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MSH6 (inh=AR+AD oe_syn=1.47 oe_mis=1.28 oe_lof=0.35), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.43 oe_lof=0.02)	.
chr2	141457909	0.1205	C	T	874		normal_dp=271;quality=QUAL=170;gene=LRP1B;variant_type=missense;coding_and_splicing=LRP1B:ENST00000389484:missense_variant:MODERATE:exon41/91:c.6709G>A:p.Gly2237Ser:;phyloP=2.3080;Sift=D(0.02);PolyPhen=B(0.40);fathmm-MKL=0.87,0.98;CADD=24.10;REVEL=0.43;COSMIC=COSM418551,COSM7207008;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=LRP1B (inh=AR oe_syn=1.09 oe_mis=0.87 oe_lof=0.23)	.
chr2	141751554	0.1474	G	A	1348		normal_dp=176;quality=QUAL=166;gene=LRP1B;variant_type=intron;coding_and_splicing=LRP1B:ENST00000389484:intron_variant:MODIFIER:exon16/90:c.2644+10C>T::;regulatory=regulatory_region_variant:enhancer;phyloP=1.0450;fathmm-MKL=0.48,0.84;CADD=13.22;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=LRP1B (inh=AR oe_syn=1.09 oe_mis=0.87 oe_lof=0.23)	.
chr2	189856241	0.1128	G	A	413		normal_dp=244;quality=QUAL=160;gene=COL3A1;variant_type=missense;coding_and_splicing=COL3A1:ENST00000304636:missense_variant:MODERATE:exon12/51:c.881G>A:p.Gly294Glu:PF01391,COL3A1:ENST00000317840:missense_variant:MODERATE:exon12/42:c.881G>A:p.Gly294Glu:PF01391;OMIM=120180 [COL3A1 Ehlers-Danlos syndrome,vascular type,130050,Autosomal dominant/Polymicrogyria with or without vascular-type EDS,618343,Autosomal recessive];;phyloP=9.1360;Sift=D(0.00),D(0.00);PolyPhen=D(1.00),D(1.00);fathmm-MKL=1.00,1.00;CADD=31.00;REVEL=0.99;COSMIC=COSM74218;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=COL3A1 (inh=AD oe_syn=1.05 oe_mis=0.59 oe_lof=0.04)	.
chr2	189858183	0.1597	C	T	387		normal_dp=74;quality=QUAL=105;gene=COL3A1;variant_type=missense&splice_region;coding_and_splicing=COL3A1:ENST00000304636:missense_variant&splice_region_variant:MODERATE:exon16/51:c.1147C>T:p.Pro383Ser:PF01391,COL3A1:ENST00000317840:missense_variant&splice_region_variant:MODERATE:exon16/42:c.1147C>T:p.Pro383Ser:;OMIM=120180 [COL3A1 Ehlers-Danlos syndrome,vascular type,130050,Autosomal dominant/Polymicrogyria with or without vascular-type EDS,618343,Autosomal recessive];;phyloP=1.3040;Sift=T(0.32),T(0.50);PolyPhen=B(0.03),B(0.01);fathmm-MKL=0.89,0.98;CADD=22.30;REVEL=0.37;MaxEntScan=7.53>7.96;dbscSNV=0.230/0.472;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=COL3A1 (inh=AD oe_syn=1.05 oe_mis=0.59 oe_lof=0.04)	.
chr2	212566773	0.1665	G	A	1709		normal_dp=252;quality=QUAL=230;gene=ERBB4;variant_type=missense;coding_and_splicing=ERBB4:ENST00000342788:missense_variant:MODERATE:exon12/28:c.1408C>T:p.His470Tyr:PF01030,ERBB4:ENST00000402597:missense_variant:MODERATE:exon12/28:c.1408C>T:p.His470Tyr:PF01030,ERBB4:ENST00000436443:missense_variant:MODERATE:exon12/27:c.1408C>T:p.His470Tyr:PF01030;OMIM=600543 [ERBB4 Amyotrophic lateral sclerosis 19,615515,Autosomal dominant];;phyloP=4.2820;Sift=D(0.01),D(0.01),D(0.01);PolyPhen=P(0.78),P(0.57),P(0.67);fathmm-MKL=0.93,0.99;CADD=25.70;REVEL=0.29;COSMIC=COSM6930066,COSM6930067;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=ERBB4 (inh=AD oe_syn=1.16 oe_mis=0.78 oe_lof=0.17)	.
chr3	38646214	0.1700	G	A	1302		normal_dp=64;quality=QUAL=98;gene=SCN5A;variant_type=splice_region&intron;coding_and_splicing=SCN5A:ENST00000333535:splice_region_variant&intron_variant:LOW:exon11/27:c.1518+6C>T::,SCN5A:ENST00000413689:splice_region_variant&intron_variant:LOW:exon11/27:c.1518+6C>T::,SCN5A:ENST00000414099:splice_region_variant&intron_variant:LOW:exon10/25:c.1518+6C>T::,SCN5A:ENST00000423572:splice_region_variant&intron_variant:LOW:exon10/26:c.1518+6C>T::,SCN5A:ENST00000425664:splice_region_variant&intron_variant:LOW:exon11/26:c.1518+6C>T::,SCN5A:ENST00000443581:splice_region_variant&intron_variant:LOW:exon11/27:c.1518+6C>T::,SCN5A:ENST00000449557:splice_region_variant&intron_variant:LOW:exon10/25:c.1518+6C>T::,SCN5A:ENST00000450102:splice_region_variant&intron_variant:LOW:exon10/25:c.1518+6C>T::,SCN5A:ENST00000451551:splice_region_variant&intron_variant:LOW:exon11/26:c.1518+6C>T::,SCN5A:ENST00000455624:splice_region_variant&intron_variant:LOW:exon10/26:c.1518+6C>T::;OMIM=600163 [SCN5A Atrial fibrillation,familial,10,614022,Autosomal dominant/Brugada syndrome 1,601144,Autosomal dominant/Cardiomyopathy,dilated,1E,601154,Autosomal dominant/Heart block,nonprogressive,113900,Autosomal dominant/Heart block,progressive,type IA,113900,Autosomal dominant/Long QT syndrome-3,603830,Autosomal dominant/Sick sinus syndrome 1,608567,Autosomal recessive/Sudden infant death syndrome,susceptibility to,272120,Autosomal recessive/Ventricular fibrillation,familial,1,603829];;phyloP=2.1320;fathmm-MKL=0.90,0.99;CADD=14.82;MaxEntScan=4.14>6.49;dbscSNV=0.001/0.032;COSMIC=COSM5897464,COSM5897465,COSM5897466;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info=SCN5A (inh=AR+AD oe_syn=0.98 oe_mis=0.77 oe_lof=0.21)	.
chr3	105377996	0.1424	G	A	1296		normal_dp=161;quality=QUAL=165;gene=CBLB;variant_type=missense;coding_and_splicing=CBLB:ENST00000264122:missense_variant:MODERATE:exon19/19:c.2767C>T:p.His923Tyr:,CBLB:ENST00000394027:missense_variant:MODERATE:exon18/18:c.2701C>T:p.His901Tyr:,CBLB:ENST00000407712:missense_variant:MODERATE:exon4/4:c.412C>T:p.His138Tyr:;phyloP=3.9420;Sift=T(0.54),T(0.93),T(0.59);PolyPhen=B(0.00),B(0.00),B(0.00);fathmm-MKL=0.90,0.98;CADD=20.90;REVEL=0.32;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=CBLB (inh=n/a oe_syn=1.03 oe_mis=0.83 oe_lof=0.14)	.
chr3	138374293	0.1579	C	T	2486		normal_dp=219;quality=QUAL=204;gene=PIK3CB;variant_type=missense;coding_and_splicing=PIK3CB:ENST00000289153:missense_variant:MODERATE:exon22/22:c.3151G>A:p.Glu1051Lys:,PIK3CB:ENST00000477593:missense_variant:MODERATE:exon23/23:c.3151G>A:p.Glu1051Lys:,PIK3CB:ENST00000544716:missense_variant:MODERATE:exon15/15:c.1504G>A:p.Glu502Lys:;phyloP=7.6530;Sift=D(0.03),D(0.03),T(0.48);PolyPhen=P(0.46),P(0.46),B(0.16);fathmm-MKL=0.99,1.00;CADD=31.00;REVEL=0.57;COSMIC=COSM317875;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info=PIK3CB (inh=n/a oe_syn=0.91 oe_mis=0.62 oe_lof=0.13)	.
chr3	168807882	0.1590	C	T	1738		normal_dp=260;quality=QUAL=235;gene=MECOM;variant_type=missense;coding_and_splicing=MECOM:ENST00000264674:missense_variant:MODERATE:exon15/17:c.2938G>A:p.Glu980Lys:,MECOM:ENST00000392736:missense_variant:MODERATE:exon14/16:c.2743G>A:p.Glu915Lys:,MECOM:ENST00000433243:missense_variant:MODERATE:exon15/17:c.2746G>A:p.Glu916Lys:,MECOM:ENST00000460814:missense_variant:MODERATE:exon12/15:c.2716G>A:p.Glu906Lys:,MECOM:ENST00000464456:missense_variant:MODERATE:exon13/15:c.2716G>A:p.Glu906Lys:,MECOM:ENST00000468789:missense_variant:MODERATE:exon14/16:c.2743G>A:p.Glu915Lys:,MECOM:ENST00000472280:missense_variant:MODERATE:exon14/16:c.2746G>A:p.Glu916Lys:,MECOM:ENST00000494292:missense_variant:MODERATE:exon14/16:c.3280G>A:p.Glu1094Lys:;regulatory=regulatory_region_variant:enhancer;OMIM=165215 [MECOM Radioulnar synostosis with amegakaryocytic thrombocytopenia 2,616738,Autosomal dominant],600049 [MECOM Myelodysplasia syndrome-1];;phyloP=4.6230;Sift=T(0.29),T(0.30),T(0.31),T(0.30),T(0.30),T(0.30),T(0.31),T(0.31);PolyPhen=B(0.01),B(0.01),B(0.01),B(0.00),B(0.17),B(0.01),B(0.01),B(0.17);fathmm-MKL=0.95,0.99;CADD=20.90;REVEL=0.19;COSMIC=COSM1693765,COSM1693766;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MECOM (inh=AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.04)	.
chr3	183210467	0.1480	G	A	1529		normal_dp=102;quality=QUAL=124;gene=KLHL6;variant_type=missense;coding_and_splicing=KLHL6:ENST00000341319:missense_variant:MODERATE:exon6/7:c.1379C>T:p.Ser460Phe:PF01344;regulatory=regulatory_region_variant:promoter_flanking_region;phyloP=9.4770;Sift=D(0.00);PolyPhen=D(1.00);fathmm-MKL=0.99,0.99;CADD=31.00;REVEL=0.91;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=KLHL6 (inh=n/a oe_syn=1.07 oe_mis=0.83 oe_lof=0.51)	.
chr3	190212686	0.1600	G	A	354		normal_dp=195;quality=QUAL=155;variant_type=intergenic;coding_and_splicing=::intergenic_variant:MODIFIER::::;phyloP=0.4420;fathmm-MKL=0.03,0.16;CADD=1.15;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info= (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr4	143045911	0.0906	C	T	935		normal_dp=146;quality=QUAL=89;gene=INPP4B;variant_type=missense&splice_region;coding_and_splicing=INPP4B:ENST00000262992:missense_variant&splice_region_variant:MODERATE:exon17/24:c.1723G>A:p.Asp575Asn:,INPP4B:ENST00000308502:missense_variant&splice_region_variant:MODERATE:exon16/23:c.1723G>A:p.Asp575Asn:,INPP4B:ENST00000508116:missense_variant&splice_region_variant:MODERATE:exon18/25:c.1723G>A:p.Asp575Asn:,INPP4B:ENST00000509777:missense_variant&splice_region_variant:MODERATE:exon19/26:c.1723G>A:p.Asp575Asn:,INPP4B:ENST00000513000:missense_variant&splice_region_variant:MODERATE:exon20/27:c.1723G>A:p.Asp575Asn:;phyloP=3.1000;Sift=D(0.03),D(0.03),D(0.03),D(0.03),D(0.03);PolyPhen=B(0.03),B(0.03),B(0.03),B(0.02),B(0.03);fathmm-MKL=0.94,0.98;CADD=24.40;REVEL=0.09;MaxEntScan=9.45>9.46;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=INPP4B (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.22)	.
chr4	143045912	0.0921	C	A	929		normal_dp=144;quality=QUAL=117;gene=INPP4B;variant_type=missense&splice_region;coding_and_splicing=INPP4B:ENST00000262992:missense_variant&splice_region_variant:MODERATE:exon17/24:c.1722G>T:p.Glu574Asp:,INPP4B:ENST00000308502:missense_variant&splice_region_variant:MODERATE:exon16/23:c.1722G>T:p.Glu574Asp:,INPP4B:ENST00000508116:missense_variant&splice_region_variant:MODERATE:exon18/25:c.1722G>T:p.Glu574Asp:,INPP4B:ENST00000509777:missense_variant&splice_region_variant:MODERATE:exon19/26:c.1722G>T:p.Glu574Asp:,INPP4B:ENST00000513000:missense_variant&splice_region_variant:MODERATE:exon20/27:c.1722G>T:p.Glu574Asp:;phyloP=0.0820;Sift=T(0.44),T(0.44),T(0.44),T(0.44),T(0.44);PolyPhen=B(0.00),B(0.00),B(0.00),B(0.00),B(0.00);fathmm-MKL=0.29,0.94;CADD=16.93;REVEL=0.02;MaxEntScan=9.45>10.86;dbscSNV=0.000/0.002;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=INPP4B (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.22)	.
chr5	37010243	0.1261	A	T	580		normal_dp=226;quality=QUAL=158;gene=NIPBL;variant_type=synonymous;coding_and_splicing=NIPBL:ENST00000282516:synonymous_variant:LOW:exon21/47:c.4476A>T:p.Ala1492=:,NIPBL:ENST00000448238:synonymous_variant:LOW:exon21/46:c.4476A>T:p.Ala1492=:;OMIM=608667 [NIPBL Cornelia de Lange syndrome 1,122470,Autosomal dominant];;phyloP=-0.2980;fathmm-MKL=0.25,0.97;CADD=10.69;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=NIPBL (inh=AD oe_syn=0.98 oe_mis=0.57 oe_lof=0.01)	.
chr5	180041065	0.1403	C	T	1285		normal_dp=83;quality=QUAL=77;gene=FLT4;variant_type=splice_region&intron;coding_and_splicing=FLT4:ENST00000261937:splice_region_variant&intron_variant:LOW:exon24/29:c.3331+3G>A::,FLT4:ENST00000393347:splice_region_variant&intron_variant:LOW:exon24/29:c.3331+3G>A::,FLT4:ENST00000502649:splice_region_variant&intron_variant:LOW:exon24/29:c.3331+3G>A::;OMIM=136352 [FLT4 Hemangioma,capillary infantile,somatic,602089/Lymphatic malformation 1,153100,Autosomal dominant];;dbSNP=rs1258606058;gnomAD=0.0001;gnomAD_hom_hemi=0,.;phyloP=1.0770;fathmm-MKL=0.71,0.97;CADD=14.22;MaxEntScan=8.73>10.24;dbscSNV=0.000/0.000;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=FLT4 (inh=AD oe_syn=1.11 oe_mis=0.71 oe_lof=0.07)	.
chr6	6269291	0.0109	C	T	963	freq-tum	normal_dp=238;quality=QUAL=56;gene=F13A1;variant_type=intron;coding_and_splicing=F13A1:ENST00000264870:intron_variant:MODIFIER:exon3/14:c.320-2249G>A::;OMIM=134570 [F13A1 Factor XIIIA deficiency,613225,Autosomal recessive/Myocardial infarction,protection against,608446/Venous thrombosis,protection against,188050,Autosomal dominant];;phyloP=-0.4160;fathmm-MKL=0.01,0.10;CADD=0.12;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=F13A1 (inh=AR oe_syn=1.05 oe_mis=0.85 oe_lof=0.48)	.
chr6	74228684	0.1748	C	T	1574		normal_dp=149;quality=QUAL=139;gene=EEF1A1;variant_type=missense;coding_and_splicing=EEF1A1:ENST00000309268:missense_variant:MODERATE:exon4/8:c.592G>A:p.Gly198Ser:PF00009,EEF1A1:ENST00000316292:missense_variant:MODERATE:exon3/7:c.592G>A:p.Gly198Ser:PF00009,EEF1A1:ENST00000331523:missense_variant:MODERATE:exon4/8:c.592G>A:p.Gly198Ser:PF00009;regulatory=regulatory_region_variant:promoter,TF_binding_site_variant;phyloP=7.4450;Sift=D(0.01),D(0.01),D(0.01);PolyPhen=P(0.82),P(0.82),P(0.82);fathmm-MKL=0.97,0.98;CADD=28.10;REVEL=0.69;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=EEF1A1 (inh=n/a oe_syn=1.70 oe_mis=0.35 oe_lof=0.06)	.
chr6	117665238	0.2036	C	T	789		normal_dp=171;quality=QUAL=207;gene=ROS1;variant_type=synonymous;coding_and_splicing=ROS1:ENST00000368507:synonymous_variant:LOW:exon28/44:c.4491G>A:p.Leu1497=:,ROS1:ENST00000368508:synonymous_variant:LOW:exon27/43:c.4509G>A:p.Leu1503=:;phyloP=1.0600;fathmm-MKL=0.04,0.22;CADD=3.85;COSMIC=COSM6930473,COSM6930474;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=ROS1 (inh=n/a oe_syn=1.11 oe_mis=1.03 oe_lof=0.93)	.
chr6	117706984	0.1845	C	T	1132		normal_dp=173;quality=QUAL=193;gene=ROS1;variant_type=synonymous;coding_and_splicing=ROS1:ENST00000368507:synonymous_variant:LOW:exon16/44:c.2151G>A:p.Thr717=:,ROS1:ENST00000368508:synonymous_variant:LOW:exon15/43:c.2166G>A:p.Thr722=:;dbSNP=rs55944128;1000g=0.0018;gnomAD=0.0034;gnomAD_hom_hemi=0,.;gnomAD_sub=0.0115,0.0003,0.0000,0.0001,0.0000;ESP_sub=0.0000,0.0125;phyloP=-1.0820;fathmm-MKL=0.02,0.19;CADD=6.05;NGSD_som_c=2;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=1;gene_info=ROS1 (inh=n/a oe_syn=1.11 oe_mis=1.03 oe_lof=0.93)	.
chr6	152420046	0.2294	C	T	1589		normal_dp=103;quality=QUAL=160;gene=ESR1;variant_type=missense,intron;coding_and_splicing=ESR1:ENST00000206249:missense_variant:MODERATE:exon8/8:c.1733C>T:p.Ser578Phe:PF12743,ESR1:ENST00000338799:missense_variant:MODERATE:exon9/9:c.1733C>T:p.Ser578Phe:PF12743,ESR1:ENST00000406599:missense_variant:MODERATE:exon4/4:c.950C>T:p.Ser317Phe:PF12743,ESR1:ENST00000427531:intron_variant:MODIFIER:exon6/6:c.851-26355C>T::,ESR1:ENST00000440973:missense_variant:MODERATE:exon10/10:c.1733C>T:p.Ser578Phe:PF12743,ESR1:ENST00000443427:missense_variant:MODERATE:exon9/9:c.1733C>T:p.Ser578Phe:PF12743,ESR1:ENST00000456483:missense_variant:MODERATE:exon8/8:c.1397C>T:p.Ser466Phe:PF12743;regulatory=regulatory_region_variant:promoter_flanking_region;OMIM=133430 [ESR1 Atherosclerosis,susceptibility to/Breast cancer,somatic,114480/Estrogen resistance,615363,Autosomal recessive/HDL response to hormone replacement,augmented/Migraine,susceptibility to,157300,Autosomal dominant/Myocardial infarction,susceptibility to,608446];;dbSNP=rs781018265;gnomAD=0.0001;gnomAD_sub=0.0000,0.0000,0.0000,0.0000,0.0001;phyloP=3.9780;Sift=D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00);PolyPhen=P(0.88),P(0.88),D(0.93), ,P(0.88),P(0.88),P(0.81);fathmm-MKL=0.91,0.94;CADD=27.50;REVEL=0.54;COSMIC=COSM224935;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=ESR1 (inh=AR oe_syn=1.09 oe_mis=0.73 oe_lof=0.04)	.
chr7	14010136	0.1081	G	A	149		normal_dp=108;quality=QUAL=95;gene=ETV1;variant_type=intron;coding_and_splicing=ETV1:ENST00000242066:intron_variant:MODIFIER:exon5/12:c.181+16127C>T::,ETV1:ENST00000343495:intron_variant:MODIFIER:exon5/12:c.181+16127C>T::,ETV1:ENST00000399357:intron_variant:MODIFIER:exon2/8:c.115+6916C>T::,ETV1:ENST00000403527:intron_variant:MODIFIER:exon2/9:c.115+6916C>T::,ETV1:ENST00000403685:intron_variant:MODIFIER:exon4/11:c.181+16127C>T::,ETV1:ENST00000405192:intron_variant:MODIFIER:exon5/11:c.235+6916C>T::,ETV1:ENST00000405218:intron_variant:MODIFIER:exon5/12:c.235+6916C>T::,ETV1:ENST00000405358:intron_variant:MODIFIER:exon4/11:c.277+6916C>T::,ETV1:ENST00000420159:intron_variant:MODIFIER:exon1/8:c.61+15605C>T::,ETV1:ENST00000430479:intron_variant:MODIFIER:exon6/13:c.235+6916C>T::;phyloP=-0.9980;fathmm-MKL=0.00,0.09;CADD=0.25;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=ETV1 (inh=AD oe_syn=1.28 oe_mis=0.84 oe_lof=0.16)	.
chr7	98574313	0.1674	G	A	2011		normal_dp=139;quality=QUAL=151;gene=TRRAP;variant_type=missense;coding_and_splicing=TRRAP:ENST00000355540:missense_variant:MODERATE:exon53/71:c.8092G>A:p.Glu2698Lys:,TRRAP:ENST00000359863:missense_variant:MODERATE:exon54/72:c.8146G>A:p.Glu2716Lys:,TRRAP:ENST00000446306:missense_variant:MODERATE:exon52/70:c.8092G>A:p.Glu2698Lys:;phyloP=9.5560;Sift=T(0.15),T(0.15),T(0.13);PolyPhen=B(0.05),B(0.02),B(0.06);fathmm-MKL=0.99,1.00;CADD=23.80;REVEL=0.26;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=TRRAP (inh=n/a oe_syn=1.10 oe_mis=0.51 oe_lof=0.03)	.
chr7	106508094	0.1747	G	A	944		normal_dp=76;quality=QUAL=101;gene=PIK3CG;variant_type=missense;coding_and_splicing=PIK3CG:ENST00000359195:missense_variant:MODERATE:exon2/11:c.88G>A:p.Ala30Thr:,PIK3CG:ENST00000440650:missense_variant:MODERATE:exon2/11:c.88G>A:p.Ala30Thr:,PIK3CG:ENST00000496166:missense_variant:MODERATE:exon2/11:c.88G>A:p.Ala30Thr:;dbSNP=rs1212203463;gnomAD=0.0001;gnomAD_sub=0.0000,0.0000,0.0000,0.0001,0.0000;phyloP=1.5440;Sift=T(0.26),T(0.26),T(0.26);PolyPhen=B(0.00),B(0.00),B(0.00);fathmm-MKL=0.36,0.29;CADD=13.44;REVEL=0.17;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=PIK3CG (inh=n/a oe_syn=1.00 oe_mis=0.78 oe_lof=0.40)	.
chr7	140453136	0.1656	A	T	2239		normal_dp=367;quality=QUAL=308;gene=BRAF;variant_type=missense;coding_and_splicing=BRAF:ENST00000288602:missense_variant:MODERATE:exon15/18:c.1799T>A:p.Val600Glu:PF07714;OMIM=164757 [BRAF Adenocarcinoma of lung,somatic,211980/Cardiofaciocutaneous syndrome,115150,Autosomal dominant/Colorectal cancer,somatic/LEOPARD syndrome 3,613707,Autosomal dominant/Melanoma,malignant,somatic/Nonsmall cell lung cancer,somatic/Noonan syndrome 7,613706,Autosomal dominant];;ClinVar=13961 [pathogenic DISEASE=Cystic epithelial invagination containing papillae lined by columnar epithelium,Neoplasm,Papillary thyroid carcinoma,Multiple myeloma,Brainstem glioma,Cutaneous melanoma,Lung adenocarcinoma,Non-small cell lung cancer,Neoplasm of brain,Neoplasm of the colon,Gastrointestinal stroma tumor,Neoplasm of the large intestine,Squamous cell carcinoma of the head and neck,Papillary renal cell carcinoma, sporadic,Malignant melanoma of skin,Glioblastoma,Ovarian Neoplasms,Lung cancer,Carcinoma of colon,Germ cell tumor, nonseminomatous,Cardio-facio-cutaneous syndrome,Astrocytoma, low-grade, somatic,not provided];;dbSNP=rs113488022;phyloP=9.2010;Sift=D(0.00);PolyPhen=D(0.96);fathmm-MKL=0.99,0.99;CADD=30.00;REVEL=0.93;COSMIC=COSM18443,COSM476,COSM6137;NGSD_som_c=97;NGSD_som_p=ALM_Schleimhautmelanom,ARO-16,Novartis,PATHO_Somatic,Roecken_CheckpointInhibitor,SomaticAndTreatment,TEST_cfDNA_ThruPLEX_Tag-seq;NGSD_hom=3;NGSD_het=3;classification_comment=[import GPD] Christopher Schroeder 2013-05-07 09:14:08 -type: lit / general -link: http://www.ncbi.nlm.nih.gov/pubmed/21663470?dopt=Abstract&holding=npg -doi: 10.1056/NEJMoa1014209 BRAF mutations in hairy-cell leukemia.  [import GPD] Christopher Schroeder 2013-05-07 09:14:45 -type: lit / general -link: http://www.ncbi.nlm.nih.gov/pubmed/22210875?dopt=Abstract&holding=npg -doi: 10.1182/blood-2011-09-379339 Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.  [import GPD] Christopher Schroeder 2013-05-02 17:26:11 -type: lit / druggable -link: http://www.nejm.org/doi/full/10.1056/NEJMc1215697?query=TOC -drugs: vemurafenib BRAF V600E Inhibition in Anaplastic Thyroid Cancer  [import GPD] Christopher Schroeder 2013-05-07 18:21:28 -type: lit / general -link: http://www.ncbi.nlm.nih.gov/pubmed/22395615?dopt=Abstract&holding=npg -doi: 10.1038/ncomms1727 Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.  [import GPD] Christopher Schroeder 2013-05-15 11:43:10 -type: lit / preclinical study -link: http://www.nature.com/nature/journal/v483/n7387/full/nature10868.html -doi: 10.1038/nature10868 -drugs: vemurafenib, cetuximab, gefitinib, panitumumab Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.  => Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8–10% of all colon cancers2, 3, 5), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.  [import GPD] Christopher Schroeder 2013-05-03 17:12:18 -type: lit / druggable -link: http://www.nejm.org/doi/full/10.1056/NEJMoa1103782 -drugs: vemurafenib Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation  [import GPD] Christopher Schroeder 2013-05-28 15:50:19 -type: lit / general -link: http://www.ncbi.nlm.nih.gov/pubmed/20818844 -doi: 10.1056/NEJMoa1002011 -drugs: vemurafenib Inhibition of mutated, activated BRAF in metastatic melanoma. => Treatment of metastatic melanoma with PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in the majority of patients.  [import GPD] Christopher Schroeder 2013-06-05 15:32:18 -type: lit / druggable -link: http://jco.ascopubs.org/content/early/2013/06/03/JCO.2012.45.7739?papetoc -doi: 10.1200/JCO.2012.45.7739 -drugs: vemurafenib Rapid Response to Vemurafenib in a Heavily Pretreated Patient With Hairy Cell Leukemia and a BRAF Mutation  [import GPD] Christopher Schroeder 2013-09-04 10:29:28 -type: lit / preclinical study -link: http://www.ncbi.nlm.nih.gov/pubmed/18676837 -doi: 10.1158/0008-5472.CAN-08-1430 -drugs: selumetinib, Trametinib Tumors harboring BRAF V600E mutations lack this negative feedback loop and are sensitive to MEK inhibitors.  [import GPD] Christopher Schroeder 2013-12-22 15:16:45 -type: lit / clinical trial -link: http://jco.ascopubs.org/content/31/35/e448?cmpid=jco_etoc_10December2013 -doi: 10.1200/JCO.2013.50.4118 -drugs: dabrafenib, Trametinib BRAF Inhibitor–Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition => First, caution must be exercised when using BRAFis in patients or populations that might harbor RAS-mutated cells, be they in skin, bowel, or other sites.  [import GPD] Christopher Schroeder 2013-06-05 15:27:37 -type: case report -link: http://jco.ascopubs.org/content/early/2013/06/03/JCO.2012.47.6143?papetoc -doi: 10.1200/JCO.2012.47.6143 -drugs: vemurafenib, radiation Dramatic Response Induced by Vemurafenib in a BRAF V600E-Mutated Lung Adenocarcinoma. Radiosensitizing effect of vemurafenib ("should probably not be combined with radiation").;gene_info=BRAF (inh=AR+AD oe_syn=1.01 oe_mis=0.48 oe_lof=0.10)	.
chr7	151947956	0.1809	G	A	1239		normal_dp=276;quality=QUAL=238;gene=KMT2C;variant_type=missense;coding_and_splicing=KMT2C:ENST00000262189:missense_variant:MODERATE:exon12/59:c.1717C>T:p.Pro573Ser:,KMT2C:ENST00000355193:missense_variant:MODERATE:exon12/60:c.1717C>T:p.Pro573Ser:;OMIM=606833 [KMT2C Kleefstra syndrome 2,617768,Autosomal dominant];;phyloP=1.0640;Sift=T(0.10),T(0.09);PolyPhen=B(0.25),B(0.44);fathmm-MKL=0.76,0.98;CADD=22.80;REVEL=0.26;COSMIC=COSM6927260,COSM6927261;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=KMT2C (inh=AD oe_syn=1.00 oe_mis=0.86 oe_lof=0.08)	.
chr8	38297867	0.1489	G	A	551		normal_dp=113;quality=QUAL=128;gene=FGFR1;variant_type=intron,synonymous;coding_and_splicing=FGFR1:ENST00000326324:intron_variant:MODIFIER:exon2/16:c.92-11914C>T::,FGFR1:ENST00000335922:synonymous_variant:LOW:exon3/19:c.24C>T:p.Phe8=:,FGFR1:ENST00000341462:intron_variant:MODIFIER:exon2/17:c.92-10401C>T::,FGFR1:ENST00000356207:intron_variant:MODIFIER:exon2/16:c.92-11914C>T::,FGFR1:ENST00000397091:intron_variant:MODIFIER:exon2/17:c.92-10401C>T::,FGFR1:ENST00000397103:intron_variant:MODIFIER:exon1/15:c.92-11914C>T::,FGFR1:ENST00000397108:intron_variant:MODIFIER:exon3/18:c.92-10401C>T::,FGFR1:ENST00000397113:intron_variant:MODIFIER:exon2/17:c.92-10401C>T::,FGFR1:ENST00000425967:intron_variant:MODIFIER:exon3/18:c.191-10401C>T::,FGFR1:ENST00000447712:intron_variant:MODIFIER:exon2/17:c.92-10401C>T::,FGFR1:ENST00000532791:intron_variant:MODIFIER:exon2/17:c.92-10401C>T::;OMIM=136350 [FGFR1 Encephalocraniocutaneous lipomatosis,613001,Somatic mosaicism/Hartsfield syndrome,615465,Autosomal dominant/Hypogonadotropic hypogonadism 2 with or without anosmia,147950,Autosomal dominant/Jackson-Weiss syndrome,123150,Autosomal dominant/Osteoglophonic dysplasia,166250,Autosomal dominant/Pfeiffer syndrome,101600,Autosomal dominant/Trigonocephaly 1,190440,Autosomal dominant];;dbSNP=rs778168231;gnomAD=0.0001;gnomAD_hom_hemi=0,.;gnomAD_sub=0.0000,0.0000,0.0002,0.0001,0.0002;phyloP=-2.2040;fathmm-MKL=0.00,0.11;CADD=0.08;COSMIC=COSM2960592;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info=FGFR1 (inh=AD oe_syn=1.16 oe_mis=0.70 oe_lof=0.10)	.
chr8	86485291	0.1669	C	T	1834		normal_dp=158;quality=QUAL=162;variant_type=intergenic;coding_and_splicing=::intergenic_variant:MODIFIER::::;dbSNP=rs940002226;phyloP=-0.3260;fathmm-MKL=0.03,0.13;CADD=1.82;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info= (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr9	139393544	0.1843	C	T	841		normal_dp=38;quality=QUAL=88;gene=NOTCH1;variant_type=intron;coding_and_splicing=NOTCH1:ENST00000277541:intron_variant:MODIFIER:exon32/33:c.6082+20G>A::;OMIM=190198 [NOTCH1 Adams-Oliver syndrome 5,616028,Autosomal dominant/Aortic valve disease 1,109730,Autosomal dominant];;phyloP=-1.3370;fathmm-MKL=0.06,0.23;CADD=2.36;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=NOTCH1 (inh=AD oe_syn=1.14 oe_mis=0.74 oe_lof=0.04)	.
chr9	139404351	0.2367	G	A	513		normal_dp=46;quality=QUAL=104;gene=NOTCH1;variant_type=missense;coding_and_splicing=NOTCH1:ENST00000277541:missense_variant:MODERATE:exon18/34:c.2803C>T:p.Pro935Ser:PF00008;OMIM=190198 [NOTCH1 Adams-Oliver syndrome 5,616028,Autosomal dominant/Aortic valve disease 1,109730,Autosomal dominant];;dbSNP=rs1230159701;phyloP=2.9870;Sift=D(0.00);PolyPhen=P(0.73);fathmm-MKL=0.93,0.97;CADD=24.70;REVEL=0.38;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=NOTCH1 (inh=AD oe_syn=1.14 oe_mis=0.74 oe_lof=0.04)	.
chr10	43612102	0.1549	G	A	688		normal_dp=98;quality=QUAL=121;gene=RET;variant_type=missense;coding_and_splicing=RET:ENST00000340058:missense_variant:MODERATE:exon12/19:c.2207G>A:p.Gly736Glu:PF07714,RET:ENST00000355710:missense_variant:MODERATE:exon12/20:c.2207G>A:p.Gly736Glu:PF07714;OMIM=164761 [RET Central hypoventilation syndrome,congenital,209880,Autosomal dominant/Hirschsprung disease,protection against,142623,Autosomal dominant/Hirschsprung disease,susceptibility to,1,142623,Autosomal dominant/Medullary thyroid carcinoma,155240,Autosomal dominant/Multiple endocrine neoplasia IIA,171400,Autosomal dominant/Multiple endocrine neoplasia IIB,162300,Autosomal dominant/Pheochromocytoma,171300,Autosomal dominant];;phyloP=9.8730;Sift=D(0.00),D(0.00);PolyPhen=D(1.00),D(1.00);fathmm-MKL=0.99,1.00;CADD=32.00;REVEL=0.97;COSMIC=COSM6962596,COSM6962597;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=RET (inh=AR+AD oe_syn=1.01 oe_mis=0.88 oe_lof=0.04)	.
chr10	70406352	0.1757	C	T	1662		normal_dp=201;quality=QUAL=199;gene=TET1;variant_type=missense;coding_and_splicing=TET1:ENST00000373644:missense_variant:MODERATE:exon4/12:c.3866C>T:p.Thr1289Met:;dbSNP=rs575341146;gnomAD=0.0001;gnomAD_hom_hemi=0,.;gnomAD_sub=0.0001,0.0001,0.0001,0.0001,0.0002;phyloP=-0.0870;Sift=T(0.10);PolyPhen=B(0.23);fathmm-MKL=0.09,0.29;CADD=15.31;REVEL=0.05;COSMIC=COSM4015294;NGSD_som_c=0;NGSD_hom=0;NGSD_het=1;gene_info=TET1 (inh=n/a oe_syn=0.98 oe_mis=0.86 oe_lof=0.09)	.
chr11	17741387	0.1995	C	T	1261		normal_dp=71;quality=QUAL=122;gene=MYOD1;variant_type=missense;coding_and_splicing=MYOD1:ENST00000250003:missense_variant:MODERATE:exon1/3:c.58C>T:p.Leu20Phe:;regulatory=regulatory_region_variant:promoter;phyloP=4.1450;Sift=D(0.05);PolyPhen=D(0.94);fathmm-MKL=0.92,0.96;CADD=28.80;REVEL=0.39;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MYOD1 (inh=n/a oe_syn=1.01 oe_mis=1.07 oe_lof=0.34)	.
chr11	59211127	0.1596	G	A	2352		normal_dp=109;quality=QUAL=130;gene=OR5A1;variant_type=synonymous;coding_and_splicing=OR5A1:ENST00000302030:synonymous_variant:LOW:exon1/1:c.486G>A:p.Gln162=:PF13853;phyloP=-0.7860;fathmm-MKL=0.25,0.97;CADD=6.61;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=OR5A1 (inh=n/a oe_syn=1.23 oe_mis=1.14 oe_lof=0.95)	.
chr11	62098324	0.1714	C	T	141	off-target	normal_dp=21;quality=QUAL=60;gene=NPM1P35;variant_type=upstream_gene;coding_and_splicing=NPM1P35:ENST00000533043:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter_flanking_region;phyloP=0.6560;fathmm-MKL=0.04,0.12;CADD=5.08;NGSD_som_c=2;NGSD_som_p=SomaticAndTreatment;NGSD_hom=0;NGSD_het=0;gene_info=NPM1P35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr11	70279245	0.1364	C	T	421		normal_dp=39;quality=QUAL=79;gene=CTTN;variant_type=synonymous;coding_and_splicing=CTTN:ENST00000301843:synonymous_variant:LOW:exon16/18:c.1305C>T:p.Gly435=:,CTTN:ENST00000346329:synonymous_variant:LOW:exon15/17:c.1194C>T:p.Gly398=:,CTTN:ENST00000376561:synonymous_variant:LOW:exon15/19:c.1194C>T:p.Gly398=:,CTTN:ENST00000538675:synonymous_variant:LOW:exon7/10:c.357C>T:p.Gly119=:;phyloP=-0.3360;fathmm-MKL=0.07,0.19;CADD=0.65;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=CTTN (inh=n/a oe_syn=1.03 oe_mis=0.87 oe_lof=0.26)	.
chr11	93528219	0.1467	C	T	1032		normal_dp=201;quality=QUAL=188;gene=MED17;variant_type=synonymous;coding_and_splicing=MED17:ENST00000251871:synonymous_variant:LOW:exon6/12:c.1005C>T:p.Pro335=:PF10156;OMIM=603810 [MED17 Microcephaly,postnatal progressive,with seizures and brain atrophy,613668,Autosomal recessive];;phyloP=-0.7080;fathmm-MKL=0.18,0.94;CADD=16.71;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MED17 (inh=AR oe_syn=0.90 oe_mis=0.85 oe_lof=0.54)	.
chr11	133495538	0.1830	A	C	987		normal_dp=161;quality=QUAL=178;variant_type=intergenic;coding_and_splicing=::intergenic_variant:MODIFIER::::;RepeatMasker=L2c (LINE/L2);phyloP=-0.2920;fathmm-MKL=0.02,0.11;CADD=2.26;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info= (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr12	460082	0.1667	G	A	18	depth-tum	normal_dp=16;depth-nor;off-target;quality=QUAL=42;gene=KDM5A;variant_type=intron;coding_and_splicing=KDM5A:ENST00000382815:intron_variant:MODIFIER:exon9/27:c.1150-137C>T::,KDM5A:ENST00000399788:intron_variant:MODIFIER:exon9/27:c.1150-137C>T::;dbSNP=rs115835122;1000g=0.0020;gnomAD=0.0015;gnomAD_hom_hemi=0,.;phyloP=-0.9010;fathmm-MKL=0.02,0.05;CADD=0.01;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=KDM5A (inh=n/a oe_syn=1.15 oe_mis=0.78 oe_lof=0.09)	.
chr12	12036213	0.6524	T	C	178	freq-nor	normal_dp=67;quality=QUAL=42;gene=ETV6;variant_type=intron;coding_and_splicing=ETV6:ENST00000396373:intron_variant:MODIFIER:exon5/7:c.1010-1166T>C::;regulatory=regulatory_region_variant:promoter_flanking_region;OMIM=600618 [ETV6 Leukemia,acute myeloid,somatic,601626/Thrombocytopenia 5,616216,Autosomal dominant];;RepeatMasker=AluSz (SINE/Alu);dbSNP=rs2723820;gnomAD=0.1040;gnomAD_hom_hemi=451,.;phyloP=-1.6490;fathmm-MKL=0.00,0.08;CADD=0.79;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=n/a (AF>5%);NGSD_het=n/a (AF>5%);NGSD_group=n/a (AF>5%);gene_info=ETV6 (inh=AD oe_syn=1.17 oe_mis=0.70 oe_lof=0.09)	.
chr12	21030706	0.1510	G	T	252		normal_dp=106;quality=QUAL=114;gene=SLCO1B3,LST3,SLCO1B7;variant_type=missense&splice_region,intron;coding_and_splicing=SLCO1B3:ENST00000261196:missense_variant&splice_region_variant:MODERATE:exon9/15:c.971G>T:p.Gly324Val:PF03137,LST3:ENST00000381541:intron_variant:MODIFIER:exon3/13:c.359+19201G>T::,SLCO1B3:ENST00000381545:missense_variant&splice_region_variant:MODERATE:exon10/16:c.971G>T:p.Gly324Val:PF03137,LST3:ENST00000540229:missense_variant&splice_region_variant:MODERATE:exon8/16:c.971G>T:p.Gly324Val:PF03137,SLCO1B3:ENST00000553473:missense_variant&splice_region_variant:MODERATE:exon8/16:c.971G>T:p.Gly324Val:PF03137,SLCO1B7:ENST00000554957:intron_variant:MODIFIER:exon3/13:c.359+19201G>T::;OMIM=605495 [SLCO1B3 Hyperbilirubinemia,Rotor type,digenic,237450,Digenic recessive];;phyloP=0.8020;Sift=D(0.00), ,D(0.00),D(0.01),D(0.01), ;PolyPhen=P(0.74), ,P(0.74),P(0.88),P(0.88), ;fathmm-MKL=0.74,0.93;CADD=22.50;REVEL=0.16;MaxEntScan=9.01>6.22;dbscSNV=0.927/0.640;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=SLCO1B3 (inh=AR oe_syn=1.05 oe_mis=1.18 oe_lof=1.19), SLCO1B7 (inh=n/a oe_syn=1.21 oe_mis=1.16 oe_lof=1.34), SLCO1B7 (inh=n/a oe_syn=1.21 oe_mis=1.16 oe_lof=1.34)	.
chr12	33031024	0.1709	C	T	478		normal_dp=34;quality=QUAL=78;gene=PKP2;variant_type=missense;coding_and_splicing=PKP2:ENST00000070846:missense_variant:MODERATE:exon3/14:c.790G>A:p.Ala264Thr:,PKP2:ENST00000340811:missense_variant:MODERATE:exon3/13:c.790G>A:p.Ala264Thr:;OMIM=602861 [PKP2 Arrhythmogenic right ventricular dysplasia 9,609040,Autosomal dominant];;phyloP=-0.7350;Sift=T(0.31),T(0.34);PolyPhen=B(0.00),B(0.00);fathmm-MKL=0.02,0.11;CADD=0.01;REVEL=0.18;COSMIC=COSM4434145;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=PKP2 (inh=AD oe_syn=0.97 oe_mis=1.00 oe_lof=0.78)	.
chr12	96106972	0.1597	C	T	1408		normal_dp=175;quality=QUAL=176;gene=NTN4;variant_type=intron;coding_and_splicing=NTN4:ENST00000343702:intron_variant:MODIFIER:exon4/9:c.991+18G>A::,NTN4:ENST00000344911:intron_variant:MODIFIER:exon5/10:c.880+18G>A::,NTN4:ENST00000538383:intron_variant:MODIFIER:exon4/9:c.880+18G>A::,NTN4:ENST00000553059:intron_variant:MODIFIER:exon4/8:c.991+18G>A::;dbSNP=rs538571907;1000g=0.0002;gnomAD=0.0001;gnomAD_hom_hemi=0,.;gnomAD_sub=0.0000,0.0000,0.0000,0.0001,0.0002;phyloP=-0.7730;fathmm-MKL=0.00,0.12;CADD=0.41;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=NTN4 (inh=n/a oe_syn=0.91 oe_mis=0.74 oe_lof=0.15)	.
chr12	106895076	0.1532	C	T	1042		normal_dp=133;quality=QUAL=122;gene=POLR3B,RP11-144F15.1;variant_type=intron;coding_and_splicing=POLR3B:ENST00000228347:intron_variant:MODIFIER:exon25/27:c.2985-25C>T::,POLR3B:ENST00000539066:intron_variant:MODIFIER:exon25/27:c.2811-25C>T::,RP11-144F15.1:ENST00000551505:intron_variant:MODIFIER:exon1/2:c.210-1116G>A::;OMIM=614366 [POLR3B Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381,Autosomal recessive];;phyloP=0.3290;fathmm-MKL=0.07,0.23;CADD=2.28;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=POLR3B (inh=AR oe_syn=0.92 oe_mis=0.63 oe_lof=0.63), RP11-144F15.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr12	133201370	0.2000	G	A	918		normal_dp=74;quality=QUAL=125;gene=POLE;variant_type=synonymous;coding_and_splicing=POLE:ENST00000320574:synonymous_variant:LOW:exon49/49:c.6774C>T:p.Phe2258=:,POLE:ENST00000535270:synonymous_variant:LOW:exon48/48:c.6693C>T:p.Phe2231=:;regulatory=regulatory_region_variant:promoter_flanking_region;OMIM=174762 [POLE Colorectal cancer,susceptibility to,12,615083,Autosomal dominant/FILS syndrome,615139,Autosomal recessive/IMAGE-I syndrome,618336,Autosomal recessive];;dbSNP=rs1209347208;gnomAD=0.0001;gnomAD_sub=0.0000,0.0000,0.0001,0.0000,0.0000;phyloP=4.2640;fathmm-MKL=0.95,0.99;CADD=17.35;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=POLE (inh=AR+AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.51)	.
chr13	32913257	0.2025	C	T	817		normal_dp=222;quality=QUAL=245;gene=BRCA2;variant_type=missense;coding_and_splicing=BRCA2:ENST00000380152:missense_variant:MODERATE:exon11/27:c.4765C>T:p.Pro1589Ser:,BRCA2:ENST00000544455:missense_variant:MODERATE:exon11/28:c.4765C>T:p.Pro1589Ser:;OMIM=600185 [BRCA2 Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Glioblastoma 3,613029,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant/Pancreatic cancer 2,613347/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Wilms tumor,194070,Autosomal dominant,Somatic mutation];;phyloP=-0.2470;Sift=T(0.19),T(0.19);PolyPhen=B(0.17),B(0.17);fathmm-MKL=0.09,0.25;CADD=11.26;REVEL=0.24;COSMIC=COSM6931433,COSM6931434;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=BRCA2 (inh=AR+AD oe_syn=0.96 oe_mis=1.07 oe_lof=0.50)	.
chr14	23899862	0.1941	C	T	652		normal_dp=55;quality=QUAL=102;gene=MYH7;variant_type=synonymous;coding_and_splicing=MYH7:ENST00000355349:synonymous_variant:LOW:exon11/40:c.906G>A:p.Leu302=:PF00063;OMIM=160760 [MYH7 Cardiomyopathy,dilated,1S,613426,Autosomal dominant/Cardiomyopathy,hypertrophic,1,192600,Autosomal dominant/Laing distal myopathy,160500,Autosomal dominant/Left ventricular noncompaction 5,613426,Autosomal dominant/Myopathy,myosin storage,autosomal dominant,608358,Autosomal dominant/Myopathy,myosin storage,autosomal recessive,255160,Autosomal recessive/Scapuloperoneal syndrome,myopathic type,181430,Autosomal dominant];;phyloP=-0.1540;fathmm-MKL=0.21,0.97;CADD=11.57;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MYH7 (inh=AR+AD oe_syn=1.23 oe_mis=0.67 oe_lof=0.45)	.
chr15	63950920	0.1925	G	A	840		normal_dp=113;quality=QUAL=147;gene=HERC1;variant_type=splice_region&intron;coding_and_splicing=HERC1:ENST00000443617:splice_region_variant&intron_variant:LOW:exon47/77:c.9425-3C>T::;OMIM=605109 [HERC1 Macrocephaly,dysmorphic facies,and psychomotor retardation,617011,Autosomal recessive];;phyloP=1.6970;fathmm-MKL=0.94,0.97;CADD=14.48;MaxEntScan=6.18>6.32;dbscSNV=0.005/0.272;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=HERC1 (inh=AR oe_syn=1.00 oe_mis=0.70 oe_lof=0.17)	.
chr15	66729162	0.1833	C	T	2499		normal_dp=147;quality=QUAL=190;gene=MAP2K1;variant_type=missense;coding_and_splicing=MAP2K1:ENST00000307102:missense_variant:MODERATE:exon3/11:c.370C>T:p.Pro124Ser:PF00069;OMIM=176872 [MAP2K1 Cardiofaciocutaneous syndrome 3,615279];;ClinVar=375981 [pathogenic DISEASE=Transitional cell carcinoma of the bladder,Cutaneous melanoma,Neoplasm of the large intestine,Malignant melanoma of skin,Malignant neoplasm of body of uterus,not provided];;dbSNP=rs1057519732;phyloP=7.7080;Sift=T(0.08);PolyPhen=D(0.99);fathmm-MKL=0.99,0.99;CADD=24.90;REVEL=0.86;COSMIC=COSM235614;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info=MAP2K1 (inh=AD oe_syn=1.08 oe_mis=0.39 oe_lof=0.14)	.
chr15	66729163	0.1835	C	T	2516		normal_dp=148;quality=QUAL=192;gene=MAP2K1;variant_type=missense;coding_and_splicing=MAP2K1:ENST00000307102:missense_variant:MODERATE:exon3/11:c.371C>T:p.Pro124Leu:PF00069;OMIM=176872 [MAP2K1 Cardiofaciocutaneous syndrome 3,615279];;ClinVar=40744 [pathogenic/likely pathogenic DISEASE=Transitional cell carcinoma of the bladder,Cutaneous melanoma,Neoplasm of the large intestine,Malignant melanoma of skin,Malignant neoplasm of body of uterus,Cardio-facio-cutaneous syndrome,not provided];;HGMD=CM071852 [CLASS=DM MUT=ALT PHEN="Cardio-facio-cutaneous syndrome" GENE=MAP2K1];;dbSNP=rs397516792;phyloP=7.7080;Sift=D(0.00);PolyPhen=D(1.00);fathmm-MKL=0.99,0.99;CADD=29.00;REVEL=0.91;COSMIC=COSM1167912,COSM1315861,COSM6986263;NGSD_som_c=6;NGSD_som_p=Novartis,SomaticAndTreatment;NGSD_hom=0;NGSD_het=0;gene_info=MAP2K1 (inh=AD oe_syn=1.08 oe_mis=0.39 oe_lof=0.14)	.
chr15	67358694	0.0833	C	T	108		normal_dp=31;quality=QUAL=59;gene=SMAD3;variant_type=missense;coding_and_splicing=SMAD3:ENST00000327367:missense_variant:MODERATE:exon1/9:c.202C>T:p.Pro68Ser:PF03165;regulatory=regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site;OMIM=603109 [SMAD3 Loeys-Dietz syndrome 3,613795,Autosomal dominant];;dbSNP=rs1307168753;gnomAD=0.0001;gnomAD_sub=0.0000,0.0000,0.0000,0.0000,0.0001;phyloP=7.3360;Sift=T(0.08);PolyPhen=P(0.61);fathmm-MKL=0.93,0.97;CADD=25.60;REVEL=0.68;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=SMAD3 (inh=AD oe_syn=1.09 oe_mis=0.39 oe_lof=0.17)	.
chr16	14016080	0.1972	A	C	366		normal_dp=99;quality=QUAL=135;gene=ERCC4;variant_type=intron;coding_and_splicing=ERCC4:ENST00000311895:intron_variant:MODIFIER:exon2/10:c.388+12A>C::,ERCC4:ENST00000575156:intron_variant:MODIFIER:exon2/5:c.388+12A>C::;OMIM=133520 [ERCC4 Fanconi anemia,complementation group Q,615272,Autosomal recessive/XFE progeroid syndrome,610965,Autosomal recessive/Xeroderma pigmentosum,group F,278760,Autosomal recessive/Xeroderma pigmentosum,type F/Cockayne syndrome,278760,Autosomal recessive];;phyloP=0.7750;fathmm-MKL=0.35,0.91;CADD=11.94;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=ERCC4 (inh=AR oe_syn=1.13 oe_mis=1.08 oe_lof=0.64)	.
chr16	14041833	0.1806	C	T	2665		normal_dp=189;quality=QUAL=216;gene=ERCC4;variant_type=missense;coding_and_splicing=ERCC4:ENST00000311895:missense_variant:MODERATE:exon11/11:c.2380C>T:p.His794Tyr:PF02732;OMIM=133520 [ERCC4 Fanconi anemia,complementation group Q,615272,Autosomal recessive/XFE progeroid syndrome,610965,Autosomal recessive/Xeroderma pigmentosum,group F,278760,Autosomal recessive/Xeroderma pigmentosum,type F/Cockayne syndrome,278760,Autosomal recessive];;dbSNP=rs757223070;gnomAD=0.0001;gnomAD_sub=0.0000,0.0001,0.0000,0.0001,0.0000;phyloP=7.2720;Sift=D(0.00);PolyPhen=D(0.99);fathmm-MKL=0.99,1.00;CADD=29.20;REVEL=0.46;NGSD_som_c=1;NGSD_som_p=Novartis;NGSD_hom=0;NGSD_het=0;gene_info=ERCC4 (inh=AR oe_syn=1.13 oe_mis=1.08 oe_lof=0.64)	.
chr16	31196694	0.1805	C	T	1087		normal_dp=178;quality=QUAL=192;gene=FUS;variant_type=intron;coding_and_splicing=FUS:ENST00000254108:intron_variant:MODIFIER:exon6/14:c.764+194C>T::,FUS:ENST00000380244:intron_variant:MODIFIER:exon6/14:c.761+194C>T::,FUS:ENST00000568685:intron_variant:MODIFIER:exon6/14:c.764+194C>T::;OMIM=137070 [FUS Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030/Essential tremor,hereditary,4,614782,Autosomal dominant];;phyloP=-0.0160;fathmm-MKL=0.08,0.41;CADD=12.57;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=FUS (inh=AR+AD oe_syn=1.24 oe_mis=0.65 oe_lof=0.10)	.
chr17	9423073	0.9091	-	C	13	depth-tum	normal_dp=2;quality=QUAL=1;gene=STX8;variant_type=intron;coding_and_splicing=STX8:ENST00000306357:intron_variant:MODIFIER:exon4/7:c.324-14595_324-14594insG::,STX8:ENST00000574431:intron_variant:MODIFIER:exon3/6:c.-10-14595_-10-14594insG::;regulatory=regulatory_region_variant:promoter_flanking_region;RepeatMasker=L2c (LINE/L2);dbSNP=rs374230429;1000g=0.8940;gnomAD=0.8547;gnomAD_hom_hemi=11327,.;CADD=16.37;NGSD_som_c=0;NGSD_hom=n/a (AF>5%);NGSD_het=n/a (AF>5%);NGSD_group=n/a (AF>5%);gene_info=STX8 (inh=n/a oe_syn=0.81 oe_mis=1.11 oe_lof=0.79)	.
chr17	10265419	0.1845	C	T	106	off-target	normal_dp=43;quality=QUAL=85;gene=MYH13;variant_type=intron;coding_and_splicing=MYH13:ENST00000252172:intron_variant:MODIFIER:exon5/40:c.505+16G>A::,MYH13:ENST00000418404:intron_variant:MODIFIER:exon4/40:c.505+16G>A::;RepeatMasker=MamTip2 (DNA/hAT-Tip100);phyloP=-0.6160;fathmm-MKL=0.01,0.13;CADD=8.62;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=MYH13 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.74)	.
chr17	17965051	0.1810	C	G	224	off-target	normal_dp=21;quality=QUAL=70;gene=GID4;variant_type=intron;coding_and_splicing=GID4:ENST00000268719:intron_variant:MODIFIER:exon4/5:c.709-108C>G::;RepeatMasker=L3 (LINE/CR1);phyloP=-0.3980;fathmm-MKL=0.01,0.12;CADD=3.51;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=GID4 (inh=n/a oe_syn=0.69 oe_mis=0.49 oe_lof=0.08)	.
chr17	38548546	0.1671	C	T	391		normal_dp=194;quality=QUAL=173;gene=TOP2A;variant_type=missense;coding_and_splicing=TOP2A:ENST00000423485:missense_variant:MODERATE:exon31/35:c.4012G>A:p.Asp1338Asn:;OMIM=126430 [TOP2A DNA topoisomerase II,resistance to inhibition of,by amsacrine];;phyloP=0.8330;Sift=T(0.22);PolyPhen=B(0.02);fathmm-MKL=0.38,0.97;CADD=22.80;REVEL=0.04;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=TOP2A (inh=n/a oe_syn=0.84 oe_mis=0.58 oe_lof=0.18)	.
chr17	40879772	0.1651	C	T	329		normal_dp=114;quality=QUAL=132;gene=EZH1;variant_type=missense,5'UTR;coding_and_splicing=EZH1:ENST00000415827:missense_variant:MODERATE:exon4/21:c.127G>A:p.Val43Met:PF11616,EZH1:ENST00000428826:missense_variant:MODERATE:exon4/21:c.127G>A:p.Val43Met:PF11616,EZH1:ENST00000435174:5_prime_UTR_variant:MODIFIER:exon4/19:c.-50G>A::,EZH1:ENST00000585893:missense_variant:MODERATE:exon4/20:c.127G>A:p.Val43Met:PF11616,EZH1:ENST00000590078:5_prime_UTR_variant:MODIFIER:exon3/20:c.-84G>A::,EZH1:ENST00000592743:missense_variant:MODERATE:exon3/20:c.127G>A:p.Val43Met:PF11616;phyloP=2.2190;Sift=T(0.13),T(0.12), ,T(0.12), ,T(0.12);PolyPhen=P(0.45),B(0.02), ,B(0.01), ,B(0.02);fathmm-MKL=0.77,0.98;CADD=22.30;REVEL=0.24;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=EZH1 (inh=n/a oe_syn=0.77 oe_mis=0.42 oe_lof=0.26)	.
chr17	57738715	0.1451	A	G	258	off-target	normal_dp=35;quality=QUAL=77;gene=CLTC;variant_type=intron;coding_and_splicing=CLTC:ENST00000269122:intron_variant:MODIFIER:exon7/31:c.1168-89A>G::,CLTC:ENST00000393043:intron_variant:MODIFIER:exon7/30:c.1168-89A>G::,CLTC:ENST00000579456:intron_variant:MODIFIER:exon3/13:c.300+13907A>G::;OMIM=118955 [CLTC Mental retardation,autosomal dominant 56,617854,Autosomal dominant];;phyloP=-0.0020;fathmm-MKL=0.26,0.90;CADD=15.25;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=CLTC (inh=AD oe_syn=0.86 oe_mis=0.27 oe_lof=0.03)	.
chr17	57738716	0.1465	G	A	276	off-target	normal_dp=37;quality=QUAL=79;gene=CLTC;variant_type=intron;coding_and_splicing=CLTC:ENST00000269122:intron_variant:MODIFIER:exon7/31:c.1168-88G>A::,CLTC:ENST00000393043:intron_variant:MODIFIER:exon7/30:c.1168-88G>A::,CLTC:ENST00000579456:intron_variant:MODIFIER:exon3/13:c.300+13908G>A::;OMIM=118955 [CLTC Mental retardation,autosomal dominant 56,617854,Autosomal dominant];;phyloP=0.4830;fathmm-MKL=0.07,0.79;CADD=14.83;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=CLTC (inh=AD oe_syn=0.86 oe_mis=0.27 oe_lof=0.03)	.
chr18	3457864	0.1127	G	T	2081		normal_dp=243;quality=QUAL=162;gene=TGIF1;variant_type=stop_gained;coding_and_splicing=TGIF1:ENST00000330513:stop_gained:HIGH:exon3/3:c.1132G>T:p.Gly378Ter:,TGIF1:ENST00000343820:stop_gained:HIGH:exon3/3:c.745G>T:p.Gly249Ter:,TGIF1:ENST00000345133:stop_gained:HIGH:exon3/3:c.685G>T:p.Gly229Ter:,TGIF1:ENST00000400167:stop_gained:HIGH:exon3/3:c.685G>T:p.Gly229Ter:,TGIF1:ENST00000401449:stop_gained:HIGH:exon4/4:c.685G>T:p.Gly229Ter:,TGIF1:ENST00000405385:stop_gained:HIGH:exon3/3:c.685G>T:p.Gly229Ter:,TGIF1:ENST00000407501:stop_gained:HIGH:exon4/4:c.745G>T:p.Gly249Ter:,TGIF1:ENST00000472042:stop_gained:HIGH:exon2/2:c.685G>T:p.Gly229Ter:,TGIF1:ENST00000548489:stop_gained:HIGH:exon3/3:c.787G>T:p.Gly263Ter:,TGIF1:ENST00000551541:stop_gained:HIGH:exon3/3:c.685G>T:p.Gly229Ter:;regulatory=regulatory_region_variant:promoter;OMIM=602630 [TGIF1 Holoprosencephaly 4,142946,Autosomal dominant];;phyloP=9.4180;fathmm-MKL=0.97,0.96;CADD=44.00;COSMIC=COSM4733414,COSM4733415;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=TGIF1 (inh=AD oe_syn=1.07 oe_mis=0.95 oe_lof=0.43)	.
chr18	38530170	0.2439	C	T	42	depth-nor	normal_dp=16;quality=QUAL=54;variant_type=intergenic;coding_and_splicing=::intergenic_variant:MODIFIER::::;RepeatMasker=(TCTT)n (Simple_repeat);phyloP=0.0380;fathmm-MKL=0.00,0.05;CADD=0.10;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info= (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr19	5215497	0.2886	G	A	385		normal_dp=34;quality=QUAL=91;gene=PTPRS;variant_type=intron;coding_and_splicing=PTPRS:ENST00000262963:intron_variant:MODIFIER:exon23/33:c.4134+12C>T::,PTPRS:ENST00000348075:intron_variant:MODIFIER:exon22/32:c.4080+12C>T::,PTPRS:ENST00000353284:intron_variant:MODIFIER:exon18/28:c.2853+12C>T::,PTPRS:ENST00000357368:intron_variant:MODIFIER:exon27/37:c.4194+12C>T::,PTPRS:ENST00000372412:intron_variant:MODIFIER:exon27/37:c.4197+12C>T::,PTPRS:ENST00000587303:intron_variant:MODIFIER:exon26/36:c.4194+12C>T::,PTPRS:ENST00000588012:intron_variant:MODIFIER:exon21/31:c.4080+12C>T::,PTPRS:ENST00000592099:intron_variant:MODIFIER:exon17/27:c.2853+12C>T::;phyloP=1.1780;fathmm-MKL=0.01,0.18;CADD=9.78;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=PTPRS (inh=n/a oe_syn=1.23 oe_mis=0.69 oe_lof=0.13)	.
chr19	7119480	0.0151	G	T	1891	freq-tum	normal_dp=182;quality=QUAL=93;gene=INSR;variant_type=synonymous;coding_and_splicing=INSR:ENST00000302850:synonymous_variant:LOW:exon21/22:c.3774C>A:p.Pro1258=:PF07714,INSR:ENST00000341500:synonymous_variant:LOW:exon20/21:c.3738C>A:p.Pro1246=:PF07714;OMIM=147670 [INSR Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549/Hyperinsulinemic hypoglycemia,familial,5,609968,Autosomal dominant/Leprechaunism,246200,Autosomal recessive/Rabson-Mendenhall syndrome,262190,Autosomal recessive];;phyloP=-6.8200;fathmm-MKL=0.02,0.20;CADD=4.50;NGSD_som_c=1;NGSD_som_p=ARO-16;NGSD_hom=0;NGSD_het=0;gene_info=INSR (inh=AR+AD oe_syn=1.06 oe_mis=0.61 oe_lof=0.32)	.
chr19	7166435	0.1730	G	A	962		normal_dp=98;quality=QUAL=123;gene=INSR;variant_type=intron;coding_and_splicing=INSR:ENST00000302850:intron_variant:MODIFIER:exon7/21:c.1611-20C>T::,INSR:ENST00000341500:intron_variant:MODIFIER:exon7/20:c.1611-20C>T::;OMIM=147670 [INSR Diabetes mellitus,insulin-resistant,with acanthosis nigricans,610549/Hyperinsulinemic hypoglycemia,familial,5,609968,Autosomal dominant/Leprechaunism,246200,Autosomal recessive/Rabson-Mendenhall syndrome,262190,Autosomal recessive];;phyloP=-0.8600;fathmm-MKL=0.01,0.10;CADD=2.26;MaxEntScan=6.21>6.11;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=INSR (inh=AR+AD oe_syn=1.06 oe_mis=0.61 oe_lof=0.32)	.
chr19	11136857	0.6212	C	T	66	depth-nor	normal_dp=11;off-target;quality=QUAL=24;gene=SMARCA4;variant_type=intron;coding_and_splicing=SMARCA4:ENST00000344626:intron_variant:MODIFIER:exon22/34:c.3169-119C>T::,SMARCA4:ENST00000358026:intron_variant:MODIFIER:exon22/35:c.3169-119C>T::,SMARCA4:ENST00000413806:intron_variant:MODIFIER:exon21/32:c.3169-119C>T::,SMARCA4:ENST00000429416:intron_variant:MODIFIER:exon23/35:c.3169-119C>T::,SMARCA4:ENST00000444061:intron_variant:MODIFIER:exon23/34:c.3169-119C>T::,SMARCA4:ENST00000450717:intron_variant:MODIFIER:exon21/32:c.3169-119C>T::,SMARCA4:ENST00000541122:intron_variant:MODIFIER:exon23/34:c.3169-119C>T::,SMARCA4:ENST00000589677:intron_variant:MODIFIER:exon23/34:c.3169-119C>T::,SMARCA4:ENST00000590574:intron_variant:MODIFIER:exon22/33:c.3169-119C>T::;OMIM=603254 [SMARCA4 Coffin-Siris syndrome 4,614609,Autosomal dominant/Rhabdoid tumor predisposition syndrome 2,613325,Autosomal dominant];;dbSNP=rs1019193;1000g=0.1655;gnomAD=0.1889;gnomAD_hom_hemi=646,.;phyloP=-1.1820;fathmm-MKL=0.03,0.10;CADD=0.18;NGSD_som_c=1;NGSD_som_p=I17R006;NGSD_hom=n/a (AF>5%);NGSD_het=n/a (AF>5%);NGSD_group=n/a (AF>5%);gene_info=SMARCA4 (inh=AD oe_syn=1.11 oe_mis=0.40 oe_lof=0.01)	.
chr19	13050003	0.1215	C	T	974		normal_dp=150;quality=QUAL=125;gene=CALR;variant_type=synonymous;coding_and_splicing=CALR:ENST00000316448:synonymous_variant:LOW:exon2/9:c.147C>T:p.Phe49=:PF00262;regulatory=regulatory_region_variant:promoter;OMIM=109091 [CALR Myelofibrosis,somatic,254450/Thrombocythemia,somatic,187950];;phyloP=-0.5590;fathmm-MKL=0.06,0.32;CADD=14.00;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=CALR (inh=AD oe_syn=1.35 oe_mis=0.91 oe_lof=0.15)	.
chr19	38948061	0.1958	C	T	529	off-target	normal_dp=24;quality=QUAL=76;gene=RYR1;variant_type=intron;coding_and_splicing=RYR1:ENST00000355481:intron_variant:MODIFIER:exon16/104:c.1792-76C>T::,RYR1:ENST00000359596:intron_variant:MODIFIER:exon16/105:c.1792-76C>T::,RYR1:ENST00000360985:intron_variant:MODIFIER:exon16/104:c.1792-76C>T::;OMIM=180901 [RYR1 Central core disease,117000,Autosomal recessive,Autosomal dominant/King-Denborough syndrome,145600,Autosomal dominant/Malignant hyperthermia susceptibility 1,145600,Autosomal dominant/Minicore myopathy with external ophthalmoplegia,255320,Autosomal recessive/Neuromuscular disease,congenital,with uniform type 1 fiber,117000,Autosomal recessive,Autosomal dominant];;dbSNP=rs1224406581;phyloP=-0.0290;fathmm-MKL=0.03,0.12;CADD=12.52;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=RYR1 (inh=AR+AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.38)	.
chr19	39017614	0.1575	C	T	424		normal_dp=55;quality=QUAL=92;gene=RYR1,AC067969.1;variant_type=intron,non_coding_transcript_exon;coding_and_splicing=RYR1:ENST00000355481:intron_variant:MODIFIER:exon70/104:c.10612-19C>T::,RYR1:ENST00000359596:intron_variant:MODIFIER:exon71/105:c.10627-19C>T::,RYR1:ENST00000360985:intron_variant:MODIFIER:exon71/104:c.10627-19C>T::,AC067969.1:ENST00000597015:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.550G>A::;OMIM=180901 [RYR1 Central core disease,117000,Autosomal recessive,Autosomal dominant/King-Denborough syndrome,145600,Autosomal dominant/Malignant hyperthermia susceptibility 1,145600,Autosomal dominant/Minicore myopathy with external ophthalmoplegia,255320,Autosomal recessive/Neuromuscular disease,congenital,with uniform type 1 fiber,117000,Autosomal recessive,Autosomal dominant];;phyloP=-0.2580;fathmm-MKL=0.03,0.14;CADD=4.39;MaxEntScan=9.67>9.64;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=RYR1 (inh=AR+AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.38), AC067969.1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	.
chr19	39061282	0.1777	C	T	1703		normal_dp=142;quality=QUAL=163;gene=RYR1;variant_type=synonymous;coding_and_splicing=RYR1:ENST00000355481:synonymous_variant:LOW:exon93/105:c.13680C>T:p.Phe4560=:PF06459,RYR1:ENST00000359596:synonymous_variant:LOW:exon94/106:c.13695C>T:p.Phe4565=:PF06459,RYR1:ENST00000360985:synonymous_variant:LOW:exon93/105:c.13680C>T:p.Phe4560=:PF06459;OMIM=180901 [RYR1 Central core disease,117000,Autosomal recessive,Autosomal dominant/King-Denborough syndrome,145600,Autosomal dominant/Malignant hyperthermia susceptibility 1,145600,Autosomal dominant/Minicore myopathy with external ophthalmoplegia,255320,Autosomal recessive/Neuromuscular disease,congenital,with uniform type 1 fiber,117000,Autosomal recessive,Autosomal dominant];;dbSNP=rs751989788;gnomAD=0.0001;gnomAD_sub=0.0000,0.0000,0.0000,0.0001,0.0000;phyloP=0.2260;fathmm-MKL=0.65,0.97;CADD=9.12;NGSD_som_c=0;NGSD_hom=0;NGSD_het=0;gene_info=RYR1 (inh=AR+AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.38)	.
